#463679
Colombia 50
Colombia 50
Scag na torthaí
Bailiúcháin
16 toradh in 9 ndoiciméad
#3000304
I bhfianaise infhaighteacht phoiblí thuarascáil bhliantúil iomlán agus chuimsitheach Quimpac de Colombia don bhliain 2022, chuaigh an Coimisiún i muinín úsáid na faisnéise a chuimsítear inti.
Given the public availability of Quimpac de Colombia’s full and comprehensive annual report for 2022, the Commission resorted to the use of the information included therein.
#3000306
Iarradh ar na páirtithe leasmhara a mbarúlacha a thabhairt ar oiriúnacht na Colóime mar thír ionadaíoch agus ar Quimpac de Colombia mar tháirgeoir i ndeighleog táirgeachta chomhchosúil sa tír ionadaíoch.
Interested parties were invited to comment on the appropriateness of Colombia as a representative country and of Quimpac de Colombia as producer in a similar production segment in the representative country.
#3241765
Chuir Xiangtan i gcoinne úsáid a bhaint as costais díola, ghinearálta agus riaracháin agus brabús Quimpac de Colombia chun an gnáthluach a ríomh, ar thrí fhoras.
Xiangtan contested the use Quimpac de Colombia’s SG&A and profit in constructing the normal value on three grounds.
#2155491
Maidir leis an gColóim, siar go 2018 a théann na sonraí airgeadais atá ar fáil go héasca le haghaidh Furukuwa Industrial Colombia S A S agus, dá thoradh sin, níorbh fhéidir a mheas go bhfuil sé oiriúnach le haghaidh na tréimhse imscrúdaithe.
With regard to Colombia, the readily available financial data for Furukuwa Industrial Colombia S A S dated back from 2018 and, as a consequence, could not be considered suitable for the investigation period.
#2743808
Úsáideadh sonraí airgeadais do na cuideachtaí seo a leanas mar a baineadh as Orbis Bureau van Dijk don bhliain airgeadais 2021: Sucroal SA, DSM Nutritional Products Colombia SA, Fonandes SAS, Nutresol SAS agus Quimica International Quintal SA.
Financial data for the following companies as extracted from Orbis Bureau van Dijk was used for the financial year 2021: Sucroal SA, DSM Nutritional Products Colombia SA, Fonandes SAS, Nutresol SAS and Quimica International Quintal SA.
#3000019
Shainaithin an Coimisiún freisin sonraí airgeadais atá ar fáil go poiblí maidir le táirgeoir aonair EMD sa tír, Quimica International Quintal S.A (‘Quintal’), agus maidir le cuideachta eile a úsáideann próiseas táirgthe den chineál céanna (cuideachtaí a úsáideann próisis leictrealaíocha ina bpróiseas táirgthe), Quimpac de Colombia S.A (‘Quimpac’).
The Commission also identified publicly available financial data of the sole producer of EMD in the country, Quimica International Quintal S.A (‘Quintal’), and of another company using the similar production process (companies that use electrolytic processes in their production process), Quimpac de Colombia S.A (‘Quimpac’).
#3000301
Sa chás sonrach sin, cuireadh iallach ar an gCoimisiún rogha mhalartach inmharthana a aimsiú agus ós rud é go raibh an próiseas táirgthe ríthábhachtach chun teacht ar na sonraí feidhmíochta airgeadais foriomlána, fuair sé amach gur cuideachta Quimpac de Colombia S.A. í a d’úsáid an próiseas leictrealaithe céanna ina tháirgeadh.
In this specific situation, the Commission was compelled to find a viable alternative and with the production process being a key determinant of the overall financial performance data, it found a company Quimpac de Colombia S.A., which use the same electrolysis process in its production.
#3000305
I bhfianaise na mbreithnithe thuas, chuir an Coimisiún na páirtithe leasmhara ar an eolas leis an Dara Nóta go raibh sé beartaithe aige an Cholóim a úsáid mar thír ionadaíoch iomchuí agus Quimpac de Colombia S.A. a úsáid chun praghsanna nó tagarmharcanna neamhshaofa a aimsiú ar mhaithe leis an ngnáthluach a ríomh, i gcomhréir le hAirteagal 2(6a)(a), an chéad fhleasc den bhun-Rialachán.
In light of the above considerations, the Commission informed the interested parties with the Second Note that it intended to use Colombia as an appropriate representative country and the Quimpac de Colombia S.A., in accordance with Article 2(6a)(a), first ident of the basic Regulation in order to source undistorted prices or benchmarks for the calculation of normal value.
#3000459
Maidir leis na costais táirgthe a suíodh mar a thuairiscítear san aithris roimhe seo, chuir an Coimisiún SG &A 20,33 % agus brabús 24,72 % Quimpac de Colombia S.A. i bhfeidhm mar a mhínítear in aithris (187), arna sloinneadh mar chéatadán de na Costais Earraí Díolta (‘COGS’).
To the costs of production established as described in the previous recital, the Commission applied SG&A of 20,33 % and profit of 24,72 % of Quimpac de Colombia S.A. as explained in recital (187), both expressed as a percentage of the Costs of Goods Sold (‘COGS’).
#3005649
Ina gcuid barúlacha leis an Nóta, d’áitigh tionscal an Aontais gurbh é taraif ‘Nivel 2’ do chustaiméirí tionsclaíocha an taraif leictreachais is infheidhme do Enel Colombia, a chomhfhreagraíonn do voltas 11,4 – 13,2 kV, seachas taraif ‘Nivel 4’ a roghnaigh an Coimisiún sa Nóta, a chomhfhreagraíonn do voltas 115 kV.
In their comments to the Note, the Union industry argued that the applicable electricity tariff of Enel Colombia would be the ‘Nivel 2’ tariff for industrial customers, corresponding to a voltage of 11,4 – 13,2 kV, rather than the ‘Nivel 4’ tariff selected by the Commission in the Note, which corresponds to a voltage of 115 kV.
#3005650
A mhéid a bhaineann leis an taraif leictreachais is infheidhme, dheimhnigh an Coimisiún go soláthraítear leictreachas don iarratasóir ag voltas 110 kV, agus dá bhrí sin, is é taraif ‘Nivel 4’ de Enel Colombia an taraif is iomchuí.
As regards the applicable electricity tariff, the Commission confirmed that the applicant is supplied with electricity at a voltage of 110 kV, and therefore, the ‘Nivel 4’ tariff of Enel Colombia is the most appropriate tariff.
#3214840
Chuir Ceanada faisnéis nuashonraithe isteach maidir leis an staid eipidéimeolaíoch i ndáil le 4 ráig den fhliú éanúil ardphataigineach i gcúigí British Colombia (2) agus Saskatchewan (2), ráigeanna a deimhníodh idir an 1 Samhain 2023 agus an 10 Samhain 2023 le hanailís saotharlainne (RT-PCR).
Canada has submitted updated information on the epidemiological situation in relation to 4 outbreaks of HPAI in the provinces of British Colombia (2) and Saskatchewan (2), which were confirmed between 1 November 2023 and 10 November 2023 by laboratory analysis (RT-PCR).
#3229587
Chuir Ceanada isteach faisnéis cothrom le dáta maidir leis an staid eipidéimeolaíoch i ndáil le seacht ráig den fhliú éanúil ardphataigineach i gcúigí Alberta (1), British Colombia (5) agus Québec (1), ráigeanna a deimhníodh idir an 20 Deireadh Fómhair 2023 agus an 3 Eanáir 2024 le hanailís saotharlainne (ISP cúl-trascrioptáise).
Canada has submitted updated information on the epidemiological situation in relation to seven outbreaks of HPAI in the provinces of Alberta (1), British Colombia (5) and Quebec (1), which were confirmed between 20 October 2023 and 3 January 2024 by laboratory analysis (RT-PCR).
#3241673
Sa Rialachán sealadach, roghnaigh an Coimisiún an Cholóim chun í a úsáid mar thír ionadaíoch agus d’úsáid sé sonraí airgeadais na cuideachta Quimpac de Colombia le haghaidh an ghnáthluacha ríofa i gcomhréir le hAirteagal 2(6a)(a) den bhun-Rialachán.
In the provisional Regulation, the Commission selected Colombia as the representative country and used the financial data of the company Quimpac de Colombia for the constructed normal value in accordance with Article 2(6a)(a) of the basic Regulation.
#3244738
Chuir Ceanada faisnéis nuashonraithe isteach maidir leis an staid eipidéimeolaíoch i ndáil le dhá ráig den fhliú éanúil ardphataigineach i gcúigí British Colombia agus Saskatchewan, ráigeanna a deimhníodh an 8 Samhain 2023 agus an 15 Eanáir 2024 le hanailís saotharlainne (RT-PCR).
Canada has submitted updated information on the epidemiological situation in relation to two outbreaks of HPAI in the provinces of British Columbia and Saskatchewan, which were confirmed on 8 November 2023 and 15 January 2024 by laboratory analysis (RT-PCR).